Purchase Order #36C26326P0503

Short-Term Purchase Order for TAVR Medical Products to Edwards Lifesciences

This award represents a short-term purchase order contract awarded to Edwards Lifesciences LLC, a leading medical technology company specializing in heart valve therapies and critical care monitoring. The contract involves the procurement of Transcatheter Aortic Valve Replacement (TAVR) devices, a minimally invasive treatment for aortic valve disease. The contract is significant as it supports the agency's efforts to provide advanced cardiovascular treatments, addressing critical health needs with innovative medical devices. The scope covers the delivery of these specialized TAVR products within a concise timeframe, ensuring timely availability for patient care or program requirements. Awarded through a competitive or direct procurement process typical of purchase orders, this contract covers a brief performance period over several days, reflecting a focused and immediate acquisition. The contract enhances the agency’s capability to access cutting-edge cardiovascular technologies critical for patient outcomes.

Description

TAVR

View original record